fructose-1,6-diphosphate has been researched along with Disease Models, Animal in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.69) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 13 (50.00) | 29.6817 |
| 2010's | 6 (23.08) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| de Oliveira, JR; Dias, HB; Donadio, MVF; Kimura, S | 1 |
| Borges, K; McDonald, TS; Neal, ES | 1 |
| Branchini, G; Catarina, AV; Da Costa, JC; De Oliveira, JR; Ferreira, F; Gonçalves, CA; Greggio, S; Leite, MC; Luft, C; Marques, EP; Nunes, FB; Rodrigues, L; Venturin, GT; Wartchow, K; Wyse, ATS | 1 |
| Hu, Y; Li, J; Ma, B; Ouyang, P; Sun, J; Wang, Y; Wu, Z; Ying, H; Zhang, Q; Zhu, J | 1 |
| Alves-Filho, JC; Cunha, FQ; Cunha, TM; Louzada-Junior, P; Paschoal, JA; Peres, RS; Pinto, LG; Saraiva, AL; Veras, FP | 1 |
| Gong, FL; Gong, Q; Hu, LY; Jin, XB; Yang, H; Yin, H; Zhu, JY | 1 |
| Lian, XY; Stringer, JL; Xu, K | 1 |
| Dai, DZ; Dai, Y; Liu, HR; Tang, XY; Ying, HJ; Zhang, Q | 1 |
| Alves-Filho, JC; Cunha, FQ; Cunha, TM; De Oliveira, JR; Ferreira, FI; Ferreira, SH; Lima, FO; Queiroz, RH; Valério, DA; Verri, WA | 1 |
| Álvares-da-Silva, MR; Alvares-Dasilva, MR; Camacho, VR; Cerski, CT; de Fraga, RS; de Oliveira, JR; Fraga, RS; Oliveira, JR | 1 |
| Cheng, YS; Dai, DZ; Dai, Y; Tang, YQ; Xu, M; Zhang, Q; Zheng, YF | 1 |
| Biancari, F; Hirvonen, J; Juvonen, T; Kaakinen, T; Kiviluoma, K; Nuutinen, M; Ohtonen, P; Pokela, M; Romsi, P; Vainionpää, V | 1 |
| Chen, YQ; Huang, WB; Jin, XJ; Tang, RH; Tao, QS; Wang, BA | 1 |
| Li, J; Li, RL; Wang, F; Xu, ED; Yuan, BL; Zhou, JP | 1 |
| Azuara, D; De Oca, J; Genescà, M; Hotter, G; Sola, A | 1 |
| Bermudez, J; Boada, J; Calafell, R; Cuesta, E; Perales, JC; Roig, T | 1 |
| Bouslama, M; Chauvière, L; Fontaine, RH; Gallego, J; Gressens, P; Matrot, B | 1 |
| Alaoja, H; Biancari, F; Dahlbacka, S; Heikkinen, J; Juvonen, T; Kaakinen, T; Kiviluoma, K; Laurila, P; Lepola, P; Nuutinen, M; Romsi, P; Salomäki, T; Tuominen, H | 1 |
| Dai, DZ; Dai, Y; Feng, Y; Ying, HJ; Zhang, Q | 1 |
| Khan, FA; Lian, XY; Stringer, JL | 1 |
| Azuma, K; Denno, R; Ebata, T; Gotoh, Y; Hasegawa, I; Hayasaka, H; Hirata, K; Ishida, K | 1 |
| Brumback, RA; Gerst, JW; Knull, HR | 1 |
| Arcadi, FA; Costa, G; De Luca, R; Imperatore, C; Ruggeri, P; Trimarchi, GR | 1 |
| Markov, AK; Olinde, KD; Rao, MR | 1 |
| Brown, EG; LeBlanc, MH; Parker, CC; Smith, EE; Vig, V | 1 |
| Gatsura, VV; Rozonov, IuB; Sernov, LN; Shal'neva, TV; Snegireva, GV; Sokolova, OA | 1 |
26 other study(ies) available for fructose-1,6-diphosphate and Disease Models, Animal
| Article | Year |
|---|---|
Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts.
Topics: Animals; Bleomycin; Collagen; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Fructose; Fructosediphosphates; Lung; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Myofibroblasts; Pulmonary Fibrosis; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1 | 2019 |
Fructose 1,6-bisphosphate is anticonvulsant and improves oxidative glucose metabolism within the hippocampus and liver in the chronic pilocarpine mouse epilepsy model.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Fructose; Fructosediphosphates; Glucose; Hippocampus; Liver; Mice; Oxidative Stress; Pilocarpine; Status Epilepticus | 2021 |
Fructose-1,6-bisphosphate preserves glucose metabolism integrity and reduces reactive oxygen species in the brain during experimental sepsis.
Topics: Animals; Brain; Brain Diseases; Disease Models, Animal; Fluorodeoxyglucose F18; Fructose; Fructosediphosphates; Glucose; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Positron Emission Tomography Computed Tomography; Reactive Oxygen Species; Sepsis | 2018 |
Strontium fructose 1, 6-diphosphate alleviate cyclophosphamide-induced oligozoospermia by improving antioxidant and inhibiting testicular apoptosis via FAS/FASL pathway.
Topics: Animals; Antineoplastic Agents, Alkylating; Antioxidants; Apoptosis; Cyclophosphamide; Disease Models, Animal; Fas Ligand Protein; fas Receptor; Fructosediphosphates; gamma-Glutamyltransferase; Glutathione; Glutathione Peroxidase; L-Iditol 2-Dehydrogenase; L-Lactate Dehydrogenase; Lipid Peroxides; Male; Malondialdehyde; Oligospermia; Organ Size; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sperm Count; Sperm Retrieval; Superoxide Dismutase; Testis; Testosterone | 2015 |
Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway.
Topics: 5'-Nucleotidase; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Antigens, CD; Apyrase; Arthritis, Experimental; Cytokines; Disease Models, Animal; Extracellular Space; Fructosediphosphates; Glycolysis; Male; Metabolic Networks and Pathways; Mice; Receptor, Adenosine A2A; Rheumatic Fever; Signal Transduction | 2015 |
Fructose-1,6-diphosphate attenuates acute lung injury induced by lipopolysaccharide in mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Disease Models, Animal; Fructosediphosphates; Interleukin-6; Lipopolysaccharides; Lung; Macrophages, Alveolar; Male; Mice; Mice, Inbred BALB C; NF-kappaB-Inducing Kinase; Nitric Oxide Synthase Type II; Peroxidase; Protein Serine-Threonine Kinases; Signal Transduction; Tumor Necrosis Factor-alpha | 2008 |
Oral administration of fructose-1,6-diphosphate has anticonvulsant activity.
Topics: 4-Butyrolactone; Action Potentials; Administration, Oral; Animals; Anticonvulsants; Brain; Cerebral Cortex; Convulsants; Disease Models, Animal; Epilepsy; Fructosediphosphates; Male; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Treatment Outcome | 2008 |
Strontium fructose 1,6-diphosphate alleviates early diabetic testopathy by suppressing abnormal testicular matrix metalloproteinase system in streptozocin-treated rats.
Topics: Acid Phosphatase; Animals; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Fructosediphosphates; gamma-Glutamyltransferase; Gene Expression; Hyperglycemia; Hypogonadism; L-Lactate Dehydrogenase; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; Succinate Dehydrogenase; Testis; Testosterone; Tissue Inhibitor of Metalloproteinases | 2009 |
Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors.
Topics: Adenosine; Analgesics; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fructosediphosphates; Hyperalgesia; Inflammation; Male; Mice; Pain Measurement; Receptor, Adenosine A1 | 2009 |
Relationship between ischemia/reperfusion injury and the stimulus of fibrogenesis in an experimental model: comparison among different preservation solutions.
Topics: Acetylcysteine; Adenosine; Alanine Transaminase; Allopurinol; Animals; Aspartate Aminotransferases; Biomarkers; Catalase; Disease Models, Animal; Fructosediphosphates; Glutathione; Insulin; L-Lactate Dehydrogenase; Liver; Liver Cirrhosis; Liver Transplantation; Male; Organ Preservation Solutions; Raffinose; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Time Factors; Transforming Growth Factor beta1 | 2011 |
Comparison of sildenafil with strontium fructose diphosphate in improving erectile dysfunction against upregulated cavernosal NADPH oxidase, protein kinase Cε, and endothelin system in diabetic rats.
Topics: Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Disease Models, Animal; Endothelin-1; Erectile Dysfunction; Fructosediphosphates; Male; Malondialdehyde; NADPH Oxidases; Piperazines; Protein Kinase C-epsilon; Purines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sildenafil Citrate; Sulfones; Superoxide Dismutase; Up-Regulation; Vasodilator Agents | 2012 |
Fructose-1,6-bisphosphate for improved outcome after hypothermic circulatory arrest in pigs.
Topics: Animals; Brain Chemistry; Brain Ischemia; Calcium; Creatine Kinase; Creatine Kinase, MB Form; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fructosediphosphates; Glucose; Glycerol; Heart Arrest, Induced; Hypothermia, Induced; Infusions, Intravenous; Isoenzymes; Lactic Acid; Neuroprotective Agents; Phosphorus; Pyruvic Acid; Random Allocation; Sodium; Survival Analysis; Swine; Time Factors; Treatment Outcome | 2003 |
[Effect of fructose-1,6-diphosphate and dexamethasone on ischemia/reperfusion injury after hemorrhagic shock in rabbits].
Topics: Animals; Cardiovascular Agents; Creatine Kinase; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Female; Fructosediphosphates; Glucocorticoids; Heart; Male; Myocardial Reperfusion Injury; Myocardium; Rabbits; Random Allocation; Shock, Hemorrhagic; Troponin I | 2004 |
[Protective effects of fructose-1,6-diphosphate on brain damage caused by febrile seizures in rats].
Topics: Animals; Brain; Disease Models, Animal; Fructosediphosphates; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures, Febrile; Treatment Outcome | 2004 |
Apoptosis inhibition during preservation by fructose-1,6-diphosphate and theophylline in rat intestinal transplantation.
Topics: Adenosine; Adenosine Triphosphate; Animals; Apoptosis; Bacterial Translocation; Disease Models, Animal; Fructosediphosphates; Ischemia; Jejunum; Male; Neutrophil Infiltration; Organ Preservation Solutions; Prospective Studies; Rats; Rats, Wistar; Reference Values; Theophylline | 2005 |
Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by D-galactosamine in rats.
Topics: Analysis of Variance; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Fructosediphosphates; Galactosamine; Hepatocytes; Histamine Release; Immunologic Factors; Inflammation; Kupffer Cells; Liver Failure, Acute; Macrophage Activation; Potassium Channels; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2006 |
Treatment-induced prevention of learning deficits in newborn mice with brain lesions.
Topics: Animals; Animals, Newborn; Behavior, Animal; Brain Injuries; Conditioning, Classical; Discrimination Learning; Disease Models, Animal; Female; Fructosediphosphates; Ibotenic Acid; Learning Disabilities; Male; Mice; Neuroprotective Agents; Odorants; Pregnancy; Time Factors | 2006 |
Fructose-1,6-bisphosphate supports cerebral energy metabolism in pigs after ischemic brain injury caused by experimental particle embolization.
Topics: Animals; Brain; Brain Ischemia; Circulatory Arrest, Deep Hypothermia Induced; Disease Models, Animal; Energy Metabolism; Fructosediphosphates; Intracranial Embolism; Lactic Acid; Neuroprotective Agents; Pyruvic Acid; Swine | 2006 |
Strontium fructose 1,6-diphosphate rescues adenine-induced male hypogonadism and upregulates the testicular endothelin-1 system.
Topics: 3-Hydroxysteroid Dehydrogenases; Adenine; Animals; Aspartic Acid Endopeptidases; Cholesterol Side-Chain Cleavage Enzyme; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Endothelin-Converting Enzymes; Fructosediphosphates; Gene Expression Regulation; Hypogonadism; Male; Metalloendopeptidases; Organ Size; Phosphoproteins; Rats; Receptor, Endothelin A; RNA, Messenger; Sexual Behavior, Animal; Signal Transduction; Sperm Count; Sperm Motility; Spermatogenesis; Strontium; Testis; Testosterone | 2007 |
Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats.
Topics: Acute Disease; Allylamine; Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Deoxyglucose; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Fructosediphosphates; Kainic Acid; Male; Meperidine; Models, Chemical; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Valproic Acid | 2007 |
[Hepatic glycolytic intermediates and glucoregulatory enzymes in septic shock due to peritonitis: experimental study in rats].
Topics: Animals; Disease Models, Animal; Fructosediphosphates; Gluconeogenesis; Glucose-6-Phosphate; Glucosephosphates; Glycolysis; Liver; Liver Glycogen; Male; Peritonitis; Phosphofructokinase-1; Pyruvate Kinase; Rats; Rats, Inbred Strains; Shock, Septic | 1984 |
High energy phosphate depletion in a model of defective muscle glycolysis.
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Fructosediphosphates; Glycogen; Glycolysis; Hexosediphosphates; Lactates; Lactic Acid; Male; Muscle Contraction; Muscle Cramp; Muscles; Myoglobinuria; Phosphocreatine; Physical Exertion; Rats; Rats, Inbred Strains | 1983 |
Effects of fructose-1,6-bisphosphate on brain polyamine biosynthesis in a model of transient cerebral ischemia.
Topics: Animals; Brain; Disease Models, Animal; Fructosediphosphates; Gerbillinae; Ischemic Attack, Transient; Male; Ornithine Decarboxylase; Polyamines | 1994 |
Protection from amphotericin B-induced lipid peroxidation in rats by fructose-1,6-diphosphate.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Fructosediphosphates; Heart; Heart Arrest; Immunologic Factors; Kidney; Lipid Peroxidation; Liver; Lung; Male; Malondialdehyde; Myocardium; Rats; Rats, Sprague-Dawley | 1997 |
Fructose-1,6-bisphosphate does not ameliorate hypoxic ischemic injury to the central nervous system in the newborn pig.
Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Disease Models, Animal; Drug Evaluation, Preclinical; Fructosediphosphates; Hypoxia, Brain; Swine; Swine Diseases; Time Factors | 1992 |
[The characteristics of the cardioprotective action of fructose-1,6-diphosphate].
Topics: Acidosis; Animals; Cardiovascular Agents; Coronary Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Fructosediphosphates; Male; Myocardial Infarction; Rabbits; Rats; Time Factors | 1991 |